Literature DB >> 5015295

Total screening of blood donations for Australia (hepatitis associated) antigen and its antibody.

J Wallace, G R Milne, A Barr.   

Abstract

During a period of one year all of 105,724 blood donations were tested for Australia (Au) antigen and its antibody by rapid immunoelectro-osmophoresis-86 (1 in 1,229) were positive for antigen and 67 (1 in 1,578) positive for antibody. Second donations by previously negative donors reduce the overall incidence of positives. Men prisoners have a significantly higher incidence of Au antigen (1 in 153) than non-institutionalized men (1 in 803). The latter have a significantly higher incidence of antigen than women (1 in 2,019). Only one antigen-positive donor was incubating acute viral hepatitis. Failure to detect one strong and one weak antigen was responsible for two cases of posttransfusion Au-antigen-positive hepatitis.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5015295      PMCID: PMC1787767          DOI: 10.1136/bmj.1.5801.663

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  Australia antigen and antibody in 10,000 Danish blood-donors.

Authors:  O Banke; E Dybkjaer; E Nordenfelt; V Reinicke
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

2.  Australia antigen and hepatitis.

Authors:  J Wallace
Journal:  Lancet       Date:  1970-09-19       Impact factor: 79.321

3.  Total screening of blood donations for H.A.A. and anti-H.A.A.

Authors:  G R Milne; A Barr; J Wallace
Journal:  Lancet       Date:  1971-01-09       Impact factor: 79.321

4.  Pitfalls of Australia antigen detection and screening.

Authors:  J Kohn; J R Morgan
Journal:  J Clin Pathol       Date:  1971-10       Impact factor: 3.411

  4 in total
  11 in total

1.  Which techniques should be used to screen blood donations for hepatitis B surface antigen?

Authors:  J Wallace; A Barr; G R Milne
Journal:  Br Med J       Date:  1975-05-24

2.  Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma.

Authors:  M L Turbitt; R S Patrick; R B Goudie; W M Buchanan
Journal:  J Clin Pathol       Date:  1977-12       Impact factor: 3.411

3.  Hepatitis B antigen in VD clinic patients.

Authors:  J Wallace
Journal:  Br Med J       Date:  1973-08-11

4.  Hepatitis B antigen (HBAg) and its antibody (HBAb) in hospital patients.

Authors:  R W Payne; A Barr; J Wallace
Journal:  J Clin Pathol       Date:  1974-02       Impact factor: 3.411

5.  A study of hepatic disease in Australia antigen and antibody-positive blood donors.

Authors:  R I Russell; D M Goldberg; J G Allan; R N MacSween; J Wallace
Journal:  Am J Dig Dis       Date:  1974-02

6.  Asymptomatic liver disease in hepatitis B antigen carriers.

Authors:  I L Woolf; B E Boyes; D M Jones; J S Whittaker; E Tapp; R N MacSween; P H Renton; F Stratton; I W Dymock
Journal:  J Clin Pathol       Date:  1974-05       Impact factor: 3.411

7.  Imprisonment, injecting drug use, and bloodborne viruses.

Authors:  O N Gill; A Noone; J Heptonstall
Journal:  BMJ       Date:  1995-02-04

8.  The emerging story of a human parvovirus-like agent.

Authors:  M J Anderson
Journal:  J Hyg (Lond)       Date:  1982-08

9.  Incidence of hepatitis B in the penitentiary of New Mexico.

Authors:  H F Hull; L H Lyons; J M Mann; S C Hadler; R Steece; M R Skeels
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

10.  Australia (hepatitis-associated) antigen in patients attending a venereal disease clinic.

Authors:  D J Jeffries; W H James; F J Jefferiss; K G MacLeod; R R Willcox
Journal:  Br Med J       Date:  1973-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.